Tiotropium Respimat(®) vs. HandiHaler(®): real‐life usage and TIOSPIR trial generalizability

AIM: Two inhaler devices (Respimat® and HandiHaler®) are available for tiotropium, a long acting anticholinergic agent. We aimed to analyze drug utilization, off‐label usage and generalizability of the TIOSPIR trial results for both devices. METHODS: Patients aged ≥18 years exhibiting at least one d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Clin Pharmacol
Auteurs principaux: Schmiedl, Sven, Fischer, Rainald, Ibanez, Luisa, Fortuny, Joan, Thürmann, Petra, Ballarin, Elena, Ferrer, Pili, Sabaté, Monica, Rottenkolber, Dominik, Gerlach, Roman, Tauscher, Martin, Reynolds, Robert, Hasford, Joerg, Rottenkolber, Marietta
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2015
Sujets:
Pharmacoepidemiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4833170/
https://ncbi.nlm.nih.gov/pubmed/26506314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12808
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires